Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck

NCT01427478 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: AFATINIB
DRUG: Placebo of AFATINIB

Sponsor

Centre Leon Berard

Collaborators

[object Object]